Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
03/16/1995 | WO1995003328A3 Melanoma-inhibiting protein |
03/16/1995 | WO1995002420A3 Prodrugs of protein tyrosine kinase inhibitors |
03/16/1995 | WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof |
03/16/1995 | WO1994026897A3 Dna encoding two fish neuropeptides |
03/16/1995 | CA2176230A1 Method and means for producing plasmaproteinase inhibitor-binding proteins |
03/16/1995 | CA2171562A1 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites |
03/16/1995 | CA2171471A1 Polar-substituted hydrocarbons |
03/16/1995 | CA2171211A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
03/16/1995 | CA2171192A1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them |
03/16/1995 | CA2171115A1 Sulfamethoxazole-specific immunosuppressive agents |
03/16/1995 | CA2171112A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
03/16/1995 | CA2170896A1 Kininogen inhibitors |
03/16/1995 | CA2170648A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
03/16/1995 | CA2169633A1 Inhibition of heparin-binding |
03/16/1995 | CA2168561A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
03/16/1995 | CA2148452A1 Method for design of substances that enhance memory and improve the quality of life |
03/15/1995 | EP0643136A1 Bacterion of Streptococcus thermophilus |
03/15/1995 | EP0643077A1 Monoclonal antibody against B70 molecule |
03/15/1995 | EP0643075A1 Novel peptide having elastase inhibitor activity and process for producing the same |
03/15/1995 | EP0643074A2 Viral infection and proliferation inhibitors |
03/15/1995 | EP0643073A1 Tripeptide antithrombotic agents |
03/15/1995 | EP0643072A1 2-Piperazinone compounds and their use |
03/15/1995 | EP0643057A1 Inhibitors of microsomal triglyceride transfer protein |
03/15/1995 | EP0642795A1 Remedy for cystic fibrosis |
03/15/1995 | EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
03/15/1995 | EP0642589A1 Method and reagent for inhibiting viral replication |
03/15/1995 | EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
03/15/1995 | EP0642580A1 Hepatocyte growth factor variants |
03/15/1995 | EP0642577A1 Antibodies with specificity for multiple adhesion molecules |
03/15/1995 | EP0642532A1 Proteinoid carriers and methods for preparation and use thereof |
03/15/1995 | EP0642530A1 Derivatives of dolastatin |
03/15/1995 | EP0642507A1 Catalytic antibodies against cocaine and methods of using and producing same |
03/15/1995 | EP0642357A1 Radiolabelled peptide compounds |
03/15/1995 | EP0642356A1 Antibodies to p-selectin and their uses |
03/15/1995 | EP0642354A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R |
03/15/1995 | EP0642353A1 Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors |
03/15/1995 | EP0642352A1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION |
03/15/1995 | EP0642351A1 New pharmaceutical uses of krill enzymes |
03/15/1995 | EP0642350A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
03/15/1995 | EP0642349A1 Use of urodilatin in pulmonary and bronchial diseases |
03/15/1995 | EP0642348A1 Antibiotic cryptdin peptides and methods of their use |
03/15/1995 | EP0642343A1 Treatment of cancers |
03/15/1995 | EP0642333A1 Method and composition for the treatment of disorders involving immunological dysfunction |
03/15/1995 | EP0642332A1 Ophthalmic compositions containing a cyclosporin. |
03/15/1995 | EP0642301A1 Pharmaceutically acceptable fixed-dried human blood platelets |
03/15/1995 | EP0580690B1 Improvements in pharmaceutical compositions |
03/15/1995 | EP0559655B1 Imidoester cross-linked hemoglobin compositions |
03/15/1995 | EP0535129B1 An anticoagulant preparation |
03/15/1995 | EP0414741B1 Further improvements relating to drug delivery systems |
03/15/1995 | CN1100104A New polypeptide compound and a process for preparation thereof |
03/15/1995 | CA2131759A1 Valine-containing pseudopeptides with antiviral activity |
03/15/1995 | CA2131758A1 Pseudopeptides with antiviral activity |
03/14/1995 | US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces |
03/14/1995 | US5397772 Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis |
03/14/1995 | US5397771 As vehicle for application of biologically active substances to mucosal membranes of mammals, dissolved or suspended |
03/14/1995 | US5397770 Yeast-derived epidermal growth factor/urogastrone-like products |
03/14/1995 | US5397703 Method for generation of antibodies to cell surface molecules |
03/14/1995 | US5397694 For treatment of periodontal disease |
03/14/1995 | US5397569 Method of treating Infectious Bursal Disease Virus infections |
03/14/1995 | US5397568 Method of treating infectious bursal disease virus infections |
03/14/1995 | CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics |
03/14/1995 | CA2131755A1 Nucleic acid-binding oligomers possessing n-branching for therapy and diagnostics |
03/14/1995 | CA2106015A1 Ribozymes having 2'-0 substituted nucleotides in the flanking sequences |
03/09/1995 | WO1995006764A2 Oligonucleotides with rna cleavage activity |
03/09/1995 | WO1995006748A1 Monoclonal antibody that induces apoptosis |
03/09/1995 | WO1995006747A1 Monoclonal antibody that recognizes interstitial cell surface antigen |
03/09/1995 | WO1995006744A2 Methods of suppressing immune response by gene therapy |
03/09/1995 | WO1995006738A1 B70(b7-2):ctla-4 bonding protein |
03/09/1995 | WO1995006736A1 BACTERIOCINS FROM $i(STREPTOCOCCUS THERMOPHILUS) |
03/09/1995 | WO1995006734A1 Cloning of a member of the serine-threonine-kinase family |
03/09/1995 | WO1995006732A2 Bacterial exported proteins and acellular vaccines based thereon |
03/09/1995 | WO1995006728A2 T cell epitopes of ryegrass pollen allergen |
03/09/1995 | WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
03/09/1995 | WO1995006726A2 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis |
03/09/1995 | WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
03/09/1995 | WO1995006718A2 Methods of suppressing autoimmune response |
03/09/1995 | WO1995006717A2 Methods of suppressing graft rejection |
03/09/1995 | WO1995006714A1 Isolation and uses of a wilson's disease gene |
03/09/1995 | WO1995006666A1 Anti-gp39 antibodies and uses therefor |
03/09/1995 | WO1995006665A1 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion |
03/09/1995 | WO1995006664A1 Dna encoding prostaglandin receptor ep2 |
03/09/1995 | WO1995006662A1 Neuron regulatory factor for promoting neuron survival |
03/09/1995 | WO1995006661A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
03/09/1995 | WO1995006660A1 Epiligrin, an epithelial ligand for integrins |
03/09/1995 | WO1995006657A1 Interleukin-10 and immunosuppression |
03/09/1995 | WO1995006656A1 Neural tissue affecting factor and compositions |
03/09/1995 | WO1995006655A1 (glycosil amide) uronic acid derivatives |
03/09/1995 | WO1995006654A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
03/09/1995 | WO1995006653A1 Glycosyl amides of 6-amino-6-deoxy sugars |
03/09/1995 | WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells |
03/09/1995 | WO1995006484A1 Lipopeptide compounds |
03/09/1995 | WO1995006481A1 Methods for inducing antigen-specific t cell tolerance |
03/09/1995 | WO1995006480A1 Methods of prolonged suppression of humoral immunity |
03/09/1995 | WO1995006479A1 Method to reduce myocardial injury during acute myocardial infarction |
03/09/1995 | WO1995006477A1 Inhibition of beta amyloid binding to glycosaminoglycans for treatment of alzheimer's disease |
03/09/1995 | WO1995006475A1 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
03/09/1995 | WO1995006474A1 Thiol-derivatized nucleosides and oligonucleosides |
03/09/1995 | WO1995006467A1 Treatment of laminitis |
03/09/1995 | WO1995006465A1 Thiol compounds for strengthening the immune system and immune reactions |
03/09/1995 | WO1995006456A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS |